EXPERIMENTAL DYSFIBRINOGENEMIA - IN-VIVO STUDIES WITH ARVIN

[1] ASHFORD A, 1968, LANCET, V1, P486

[2] BARLOW G H, 1970, Research Communications in Chemical Pathology and Pharmacology, V1, P39

[3] BELL WR, 1968, LANCET, V1, P490

[4] MANAGEMENT OF PRIAPISM BY THERAPEUTIC DEFIBRINATION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (12) : 649 - &

[5] N-TERMINAL DISULPHIDE KNOT OF HUMAN FIBRINOGEN [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1969, 17 (02) : 145 - &

[6] CHAN KE, 1963, FIBRINOGEN FIBRIN TU

[7] POLYMORPHISM IN FIBRINOGEN AGGREGATES [J]. JOURNAL OF MOLECULAR BIOLOGY, 1966, 22 (02) : 385 - &

[8] ELLIS BC, 1961, J LAB CLIN MED, V58, P477

[9] PROTEOLYTIC ACTION OF ARVIN ON HUMAN FIBRINOGEN [J]. BIOCHEMICAL JOURNAL, 1969, 115 (03) : P17 - &

[10] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) : 896 - &

[1] ASHFORD A, 1968, LANCET, V1, P486

[2] BARLOW G H, 1970, Research Communications in Chemical Pathology and Pharmacology, V1, P39

[3] BELL WR, 1968, LANCET, V1, P490

[4] MANAGEMENT OF PRIAPISM BY THERAPEUTIC DEFIBRINATION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (12) : 649 - &

[5] N-TERMINAL DISULPHIDE KNOT OF HUMAN FIBRINOGEN [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1969, 17 (02) : 145 - &

[6] CHAN KE, 1963, FIBRINOGEN FIBRIN TU

[7] POLYMORPHISM IN FIBRINOGEN AGGREGATES [J]. JOURNAL OF MOLECULAR BIOLOGY, 1966, 22 (02) : 385 - &

[8] ELLIS BC, 1961, J LAB CLIN MED, V58, P477

[9] PROTEOLYTIC ACTION OF ARVIN ON HUMAN FIBRINOGEN [J]. BIOCHEMICAL JOURNAL, 1969, 115 (03) : P17 - &

[10] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) : 896 - &